Production of pigs transgenic for human DAF: A strategy for xenotransplantation
- 1 August 1995
- journal article
- Published by Wiley in Xenotransplantation
- Vol. 2 (3), 213-217
- https://doi.org/10.1111/j.1399-3089.1995.tb00097.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- TISSUE EXPRESSION OF HUMAN COMPLEMENT INHIBITOR, DECAY-ACCELERATING FACTOR, IN TRANSGENIC PIGS A POTENTIAL APPROACH FOR PREVENTING XENOGRAFT REJECTIONTransplantation, 1995
- THE EFFECT OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON HYPERACUTE REJECTION OF PORCINE XENOGRAFTSTransplantation, 1994
- Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism.The Journal of Experimental Medicine, 1992
- Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complementTransplant International, 1992
- INHIBITION OF COMPLEMENT-MEDIATED ENDOTHELIAL CELL CYTOTOXICITY BY DECAY-ACCELERATING FACTORTransplantation, 1991
- Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.The Journal of Experimental Medicine, 1991
- Genetic Engineering of LivestockScience, 1989
- Separation of self from non-self in the complement systemImmunology Today, 1987
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985